Artiva Biotherapeutics Funding: $198M Raised, Series B
Artiva Biotherapeutics is based in San Diego. It has raised $198M in total funding. Latest round: Series B.
Artiva Biotherapeutics funding overview
Artiva Biotherapeutics is based in San Diego. Artiva Biotherapeutics has raised $198M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2021. The round record for Artiva Biotherapeutics runs through 2021; nothing later has been disclosed. Investors on record include 5AM Ventures, venBio Partners, RA Capital Management, Medivate Partners, Venrock, Frazier Healthcare Partners and 10 others. 16 distinct backers are named across the disclosed rounds.
Artiva Biotherapeutics at a glance
Total raised
$198M
Latest round
Series B
Latest round date
February 2021
Headquarters
San Diego
Notable investors
5AM Ventures, venBio Partners, RA Capital Management, Medivate Partners, Venrock, Frazier Healthcare Partners, Acuta Capital Partners, Cormorant Asset Management
Frequently asked about Artiva Biotherapeutics funding
How much has Artiva Biotherapeutics raised?
Artiva Biotherapeutics has raised $198M in total disclosed funding across the rounds on record.
Who has invested in Artiva Biotherapeutics?
5AM Ventures, venBio Partners, RA Capital Management, Medivate Partners, Venrock, Frazier Healthcare Partners are named among the investors backing Artiva Biotherapeutics.
What was the latest Artiva Biotherapeutics funding round?
The most recent disclosed round is a Series B, announced in February 2021.
Where is Artiva Biotherapeutics based?
Artiva Biotherapeutics is based in San Diego.
When did Artiva Biotherapeutics last raise?
The last disclosed Artiva Biotherapeutics round closed in February 2021 at Series B.
Round data for Artiva Biotherapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Diego and backer lists below.
